Kiley Juergens Wealth Management, LLC Glaukos Corp Transaction History

Kiley Juergens Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$52.18 - $67.93 $782 - $1,018	-15 Closed	0 $0
Q2 2018 Jul 23, 2018	BUY	$27.62 - $44.51 $414 - $667	15 New	15 $0
Q1 2018 Apr 23, 2018	SELL	$26.05 - $34.5 $390 - $517	-15 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$24.5 - $36.01 $367 - $540	15	15 $0

303

47M

75.3K

157K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.2B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Kiley Juergens Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kiley Juergens Wealth Management, LLC with notifications on news.